BIO community is buzzing after the dValueChain v1.0 launch. Despite a market correction attributed to whale profit-taking, sentiment is optimistic, citing a Pfizer pilot, Binance Labs backing, and 12 active BioDAOs funding live research.
Disclaimer: Includes third-party opinions. No financial advice. May include sponsored content.See T&Cs.